AAPL307.92+13.54 (+4.60%) ▲|ABBV258.75+7.69 (+3.06%) ▲|ABT95.06+2.88 (+3.12%) ▲|ACN137.59+6.46 (+4.93%) ▲|ADBE221.29+10.31 (+4.89%) ▲|AMAT582.22-68.69 (-10.55%) ▼|AMD508.29-32.59 (-6.03%) ▼|AMGN370.97+9.64 (+2.67%) ▲|AMT167.10+1.02 (+0.61%) ▲|AMZN244.18+2.48 (+1.02%) ▲|AVGO358.48-10.86 (-2.94%) ▼|AXP349.14+2.09 (+0.60%) ▲|BA223.36+4.78 (+2.19%) ▲|BAC58.41+0.05 (+0.08%) ▲|BKNG182.11-0.53 (-0.29%) ▼|BLK990.65+10.27 (+1.05%) ▲|BMY57.13+1.32 (+2.36%) ▲|BNY145.30-0.72 (-0.49%) ▼|BRK-B505.86+6.12 (+1.22%) ▲|C138.41-1.72 (-1.23%) ▼|CAT952.74-38.67 (-3.90%) ▼|CL94.85+2.09 (+2.25%) ▲|CMCSA23.33-0.41 (-1.71%) ▼|COF203.34-1.48 (-0.72%) ▼|COP103.65+0.43 (+0.41%) ▲|COST948.52+23.85 (+2.58%) ▲|CRM165.63+2.40 (+1.47%) ▲|CSCO112.42-4.60 (-3.93%) ▼|CVS103.51-1.30 (-1.24%) ▼|CVX168.28+2.59 (+1.56%) ▲|DE616.89-10.75 (-1.71%) ▼|DHR196.52+2.80 (+1.45%) ▲|DIS98.04+2.33 (+2.43%) ▲|DUK128.25+2.48 (+1.97%) ▲|EMR137.50-2.02 (-1.45%) ▼|FDX311.28-2.61 (-0.83%) ▼|GD369.77+8.50 (+2.35%) ▲|GE374.86-0.08 (-0.02%) ▼|GEV1,096.07-38.29 (-3.38%) ▼|GILD129.82+3.85 (+3.05%) ▲|GM74.40-1.12 (-1.49%) ▼|GOOG353.34-4.55 (-1.27%) ▼|GOOGL356.52-4.70 (-1.30%) ▼|GS1,011.89-7.73 (-0.76%) ▼|HD354.31+3.47 (+0.99%) ▲|HON226.01+4.26 (+1.92%) ▲|IBM285.80-0.45 (-0.16%) ▼|INTC119.47-7.55 (-5.94%) ▼|INTU275.16+8.08 (+3.03%) ▲|ISRG421.27+18.89 (+4.69%) ▲|JNJ261.48+7.50 (+2.95%) ▲|JPM332.72-1.35 (-0.40%) ▼|KO83.07+1.78 (+2.18%) ▲|LIN545.31+11.76 (+2.20%) ▲|LLY1,207.93+16.19 (+1.36%) ▲|LMT537.11+15.29 (+2.93%) ▲|LOW224.59+2.67 (+1.20%) ▲|LRCX346.53-44.73 (-11.43%) ▼|MA536.68+14.24 (+2.73%) ▲|MCD278.21+8.78 (+3.26%) ▲|MDLZ60.43+1.08 (+1.82%) ▲|MDT82.49+3.29 (+4.15%) ▲|META584.66-28.25 (-4.61%) ▼|MMM159.84-0.13 (-0.08%) ▼|MO72.28+0.74 (+1.03%) ▲|MRK128.13+2.76 (+2.20%) ▲|MS212.02+0.16 (+0.08%) ▲|MSFT390.75+6.47 (+1.68%) ▲|MU962.11-70.17 (-6.80%) ▼|NEE87.29+0.92 (+1.06%) ▲|NFLX78.19+4.00 (+5.39%) ▲|NKE43.95+0.89 (+2.07%) ▲|NOW106.02+0.22 (+0.21%) ▲|NVDA193.10-4.48 (-2.27%) ▼|ORCL139.27-3.23 (-2.27%) ▼|PEP143.74+2.58 (+1.83%) ▲|PFE24.28+0.40 (+1.65%) ▲|PG151.04+3.61 (+2.45%) ▲|PLTR131.35+5.62 (+4.47%) ▲|PM180.47+2.78 (+1.56%) ▲|QCOM173.30-8.62 (-4.74%) ▼|RTX196.72+4.94 (+2.58%) ▲|SBUX104.01+0.62 (+0.60%) ▲|SCHW96.54+0.76 (+0.79%) ▲|SO97.26+2.14 (+2.25%) ▲|SPG224.69+1.69 (+0.76%) ▲|T20.12-0.37 (-1.78%) ▼|TMO520.06+6.73 (+1.31%) ▲|TMUS174.81+1.75 (+1.01%) ▲|TSLA392.09-33.22 (-7.81%) ▼|TXN289.85-8.57 (-2.87%) ▼|UBER73.36+0.70 (+0.96%) ▲|UNH422.34-4.20 (-0.98%) ▼|UNP280.32+2.59 (+0.93%) ▲|UPS109.48-0.07 (-0.06%) ▼|USB61.30-0.66 (-1.07%) ▼|V359.66+8.58 (+2.44%) ▲|VZ41.48-0.52 (-1.23%) ▼|WFC85.18-0.76 (-0.88%) ▼|WMT111.84+3.02 (+2.77%) ▲|XOM136.93+0.65 (+0.48%) ▲|AAPL307.92+13.54 (+4.60%) ▲|ABBV258.75+7.69 (+3.06%) ▲|ABT95.06+2.88 (+3.12%) ▲|ACN137.59+6.46 (+4.93%) ▲|ADBE221.29+10.31 (+4.89%) ▲|AMAT582.22-68.69 (-10.55%) ▼|AMD508.29-32.59 (-6.03%) ▼|AMGN370.97+9.64 (+2.67%) ▲|AMT167.10+1.02 (+0.61%) ▲|AMZN244.18+2.48 (+1.02%) ▲|AVGO358.48-10.86 (-2.94%) ▼|AXP349.14+2.09 (+0.60%) ▲|BA223.36+4.78 (+2.19%) ▲|BAC58.41+0.05 (+0.08%) ▲|BKNG182.11-0.53 (-0.29%) ▼|BLK990.65+10.27 (+1.05%) ▲|BMY57.13+1.32 (+2.36%) ▲|BNY145.30-0.72 (-0.49%) ▼|BRK-B505.86+6.12 (+1.22%) ▲|C138.41-1.72 (-1.23%) ▼|CAT952.74-38.67 (-3.90%) ▼|CL94.85+2.09 (+2.25%) ▲|CMCSA23.33-0.41 (-1.71%) ▼|COF203.34-1.48 (-0.72%) ▼|COP103.65+0.43 (+0.41%) ▲|COST948.52+23.85 (+2.58%) ▲|CRM165.63+2.40 (+1.47%) ▲|CSCO112.42-4.60 (-3.93%) ▼|CVS103.51-1.30 (-1.24%) ▼|CVX168.28+2.59 (+1.56%) ▲|DE616.89-10.75 (-1.71%) ▼|DHR196.52+2.80 (+1.45%) ▲|DIS98.04+2.33 (+2.43%) ▲|DUK128.25+2.48 (+1.97%) ▲|EMR137.50-2.02 (-1.45%) ▼|FDX311.28-2.61 (-0.83%) ▼|GD369.77+8.50 (+2.35%) ▲|GE374.86-0.08 (-0.02%) ▼|GEV1,096.07-38.29 (-3.38%) ▼|GILD129.82+3.85 (+3.05%) ▲|GM74.40-1.12 (-1.49%) ▼|GOOG353.34-4.55 (-1.27%) ▼|GOOGL356.52-4.70 (-1.30%) ▼|GS1,011.89-7.73 (-0.76%) ▼|HD354.31+3.47 (+0.99%) ▲|HON226.01+4.26 (+1.92%) ▲|IBM285.80-0.45 (-0.16%) ▼|INTC119.47-7.55 (-5.94%) ▼|INTU275.16+8.08 (+3.03%) ▲|ISRG421.27+18.89 (+4.69%) ▲|JNJ261.48+7.50 (+2.95%) ▲|JPM332.72-1.35 (-0.40%) ▼|KO83.07+1.78 (+2.18%) ▲|LIN545.31+11.76 (+2.20%) ▲|LLY1,207.93+16.19 (+1.36%) ▲|LMT537.11+15.29 (+2.93%) ▲|LOW224.59+2.67 (+1.20%) ▲|LRCX346.53-44.73 (-11.43%) ▼|MA536.68+14.24 (+2.73%) ▲|MCD278.21+8.78 (+3.26%) ▲|MDLZ60.43+1.08 (+1.82%) ▲|MDT82.49+3.29 (+4.15%) ▲|META584.66-28.25 (-4.61%) ▼|MMM159.84-0.13 (-0.08%) ▼|MO72.28+0.74 (+1.03%) ▲|MRK128.13+2.76 (+2.20%) ▲|MS212.02+0.16 (+0.08%) ▲|MSFT390.75+6.47 (+1.68%) ▲|MU962.11-70.17 (-6.80%) ▼|NEE87.29+0.92 (+1.06%) ▲|NFLX78.19+4.00 (+5.39%) ▲|NKE43.95+0.89 (+2.07%) ▲|NOW106.02+0.22 (+0.21%) ▲|NVDA193.10-4.48 (-2.27%) ▼|ORCL139.27-3.23 (-2.27%) ▼|PEP143.74+2.58 (+1.83%) ▲|PFE24.28+0.40 (+1.65%) ▲|PG151.04+3.61 (+2.45%) ▲|PLTR131.35+5.62 (+4.47%) ▲|PM180.47+2.78 (+1.56%) ▲|QCOM173.30-8.62 (-4.74%) ▼|RTX196.72+4.94 (+2.58%) ▲|SBUX104.01+0.62 (+0.60%) ▲|SCHW96.54+0.76 (+0.79%) ▲|SO97.26+2.14 (+2.25%) ▲|SPG224.69+1.69 (+0.76%) ▲|T20.12-0.37 (-1.78%) ▼|TMO520.06+6.73 (+1.31%) ▲|TMUS174.81+1.75 (+1.01%) ▲|TSLA392.09-33.22 (-7.81%) ▼|TXN289.85-8.57 (-2.87%) ▼|UBER73.36+0.70 (+0.96%) ▲|UNH422.34-4.20 (-0.98%) ▼|UNP280.32+2.59 (+0.93%) ▲|UPS109.48-0.07 (-0.06%) ▼|USB61.30-0.66 (-1.07%) ▼|V359.66+8.58 (+2.44%) ▲|VZ41.48-0.52 (-1.23%) ▼|WFC85.18-0.76 (-0.88%) ▼|WMT111.84+3.02 (+2.77%) ▲|XOM136.93+0.65 (+0.48%) ▲|
37.8 C
New York
Thursday, July 2, 2026

Tag: SAFE

newssourceFORcompanyinformationcontent1releasesmarket

Une première autorisation de distribution de la fleur de cannabis médicinal à des fins thérapeutiques délivrée par le ministère de la Santé italien pour...

SAVONE, Italie, 25 juin 2025 (GLOBE NEWSWIRE) -- Tilray Medical, ci-après « Tilray », une division de Tilray Brands, Inc. (NASDAQ : TLRY et TSX : TLRY) et un leader mondial du cannabis thérapeutique permettant aux patients comme aux professionnels de santé de prendre ensemble des décisions de santé individualisées éclairées, annonce ce jour un virage majeur dans son développement en Europe avec l’introduction de trois nouvelles variétés de fleur de cannabis thérapeutique en Italie. Via sa filiale en propriété exclusive FL Group, Tilray devient la première entreprise italienne à décrocher l’autorisation officielle du Ministero della Salute (le ministère italien de la Santé) d’importer et distribuer de la fleur de cannabis médicinal de la marque maison Tilray Medical à des fins thérapeutiques.

Hewelth BioClear Launches as Breakthrough In-Home Laser Solution to Support Healthier Nail Appearance

Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use 
Dermatologist-Endorsed Low-Level Laser Device Introduced to Enhance Nail Appearance Through Non-Invasive At-Home Use

Glokore Light Therapy Mask Earns Spotlight as Non-Invasive Red Light Skincare Solution Backed by User Satisfaction

LED-Based Skincare Device Highlighted for Non-Invasive Anti-Aging and Acne Support Backed by Clinical Usage Data 
LED-Based Skincare Device Highlighted for Non-Invasive Anti-Aging and Acne Support Backed by Clinical Usage Data

ProZenith Ingredients Researched: The Science Behind the Popular Formula

Plant-Based Ingredients, Scientific Research, and Mineral Synergy Come Together in This Modern Approach to Natural Weight Support 
Plant-Based Ingredients, Scientific Research, and Mineral Synergy Come Together in This Modern Approach to Natural Weight Support

Celebrate the Wonderfully Weird: The Oddities and Curiosities Expo Descends on New Orleans

Enjoy a showcase of all things weird. NEW ORLEANS, June 24, 2025 /PRNewswire/ -- Brace yourselves for the strangest and most exciting event of the year...

Step into the Strange: The Oddities and Curiosities Expo Comes Alive in Grand Rapids

GRAND RAPIDS, Mich., June 24, 2025 /PRNewswire/ -- Brace yourselves for the strangest and most exciting event of the year as The Oddities and...

The Macabre Meets Motor City: The Oddities and Curiosities Expo Rolls Into Detroit

Enjoy a showcase of all things weird. DETROIT, June 24, 2025 /PRNewswire/ -- Brace yourselves for the strangest and most exciting event of the year as...

Ron Simon & Associates Files First Salmonella Lawsuit Against August Egg Company as the Number of Confirmed Outbreak Victims Approaches 100

SAN FRANCISCO, June 24, 2025 /PRNewswire/ -- The national food poisoning law firm of Ron Simon & Associates, along with Gomez Trial Attorneys, has filed...

2025 KIA K4 EARNS 2025 IIHS TOP SAFETY PICK+ AWARD

IRVINE, Calif., June 24, 2025 /PRNewswire/ -- The 2025 Kia K4 has been awarded the Insurance Institute for Highway Safety's (IIHS) highest safety rating, the...

2025 KIA K4 EARNS 2025 IIHS TOP SAFETY PICK+ AWARD

IRVINE, Calif., June 24, 2025 /PRNewswire/ -- The 2025 Kia K4 has been awarded the Insurance Institute for Highway Safety's (IIHS) highest safety rating, the...

SciSparc Announces 1-for-21 Reverse Share Split

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held 
Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicly held

Parkland Corporation Announces Results of the 2025 Annual and Special Meeting of Shareholders

CALGARY, AB, June 24, 2025 /CNW/ - Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) held its annual and special meeting of...

Parkland Corporation Announces Results of the 2025 Annual and Special Meeting of Shareholders

CALGARY, AB, June 24, 2025 /PRNewswire/ - Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) held its annual and special meeting of...

Parkland Corporation Announces Results of the 2025 Annual and Special Meeting of Shareholders

CALGARY, AB, June 24, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) held its annual and special...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSAFE

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers